DE602004004775D1 - Verfahren zur Diagnose von Leberfibrose. - Google Patents

Verfahren zur Diagnose von Leberfibrose.

Info

Publication number
DE602004004775D1
DE602004004775D1 DE602004004775T DE602004004775T DE602004004775D1 DE 602004004775 D1 DE602004004775 D1 DE 602004004775D1 DE 602004004775 T DE602004004775 T DE 602004004775T DE 602004004775 T DE602004004775 T DE 602004004775T DE 602004004775 D1 DE602004004775 D1 DE 602004004775D1
Authority
DE
Germany
Prior art keywords
liver fibrosis
severity
optionally
measuring
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004004775T
Other languages
English (en)
Other versions
DE602004004775T2 (de
Inventor
Ursula Dr Wienhues-Thelen
Hendrik Dr Huedig
Paul Cales
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Universite dAngers
Original Assignee
Roche Diagnostics GmbH
Universite dAngers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH, Universite dAngers filed Critical Roche Diagnostics GmbH
Publication of DE602004004775D1 publication Critical patent/DE602004004775D1/de
Application granted granted Critical
Publication of DE602004004775T2 publication Critical patent/DE602004004775T2/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DE602004004775T 2004-08-12 2004-10-28 Verfahren zur Diagnose von Leberfibrose. Active DE602004004775T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04019134 2004-08-12
EP04019134 2004-08-12
EP04025621A EP1626280B1 (de) 2004-08-12 2004-10-28 Verfahren zur Diagnose von Leberfibrose.

Publications (2)

Publication Number Publication Date
DE602004004775D1 true DE602004004775D1 (de) 2007-03-29
DE602004004775T2 DE602004004775T2 (de) 2007-11-22

Family

ID=34981126

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004004775T Active DE602004004775T2 (de) 2004-08-12 2004-10-28 Verfahren zur Diagnose von Leberfibrose.

Country Status (9)

Country Link
US (1) US20070178443A1 (de)
EP (1) EP1626280B1 (de)
JP (1) JP4516124B2 (de)
CN (1) CN101023356A (de)
AT (1) ATE354097T1 (de)
CA (1) CA2575475C (de)
DE (1) DE602004004775T2 (de)
ES (1) ES2282780T3 (de)
WO (1) WO2006015874A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100999720B1 (ko) 2008-11-13 2010-12-08 아주대학교산학협력단 간 경변 진단을 위한 분석방법
JP5676275B2 (ja) * 2008-12-24 2015-02-25 学校法人慶應義塾 酸化ストレス検出用マーカー、肝臓疾患マーカー及び医薬品の検定方法
KR101018960B1 (ko) 2009-02-23 2011-03-02 아주대학교산학협력단 유의성있는 간섬유화 진단을 위한 분석 방법
JP5887141B2 (ja) * 2009-02-26 2016-03-16 ユニバーシティ ダンガース 肝線維症または肝硬変の向上した診断方法
WO2010106140A1 (en) * 2009-03-19 2010-09-23 Universite D'angers Non-invasive method for assessing liver fibrosis progression
KR20120041175A (ko) * 2009-05-14 2012-04-30 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 미량 존재하는 인간 혈장 단백질 바이오마커의 신규 패널을 이용한 간성 섬유증의 임상적 진단
EP2327988A1 (de) 2009-11-28 2011-06-01 Assistance Publique Hôpitaux De Paris Verfahren zur Diagnose von fibrotischen Erkrankungen
NZ606236A (en) * 2010-07-08 2014-09-26 Univ Louisiana State Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease
CN102302358B (zh) * 2011-06-29 2014-04-09 内蒙古福瑞医疗科技股份有限公司 肝纤维化检测系统
BR112013033595A2 (pt) * 2011-06-29 2017-01-24 Inner Mongolia Furui Medical Science Co Ltd aparelhagem e sistema de detecção de fibrose hepática
CN102636642B (zh) * 2012-04-06 2014-04-30 中国人民解放军第三0二医院 一种肝纤维化诊断的快速定量试纸条的制备方法
ES2523903B1 (es) * 2013-04-30 2015-09-09 Fundación Pública Andaluza Progreso Y Salud Método de obtención de datos útiles para el diagnóstico diferencial de la fibrosis hepática
EP3027115B1 (de) * 2013-08-02 2023-09-06 Echosens Nichtinvasives system zur berechnung eines menschlichen oder tierischen, zuverlässigen, standardisierten und vollständigen scores
MX356444B (es) * 2013-09-24 2018-05-21 Univ Mexico Nac Autonoma Arreglo múltiple de anticuerpos específicos para el pronóstico, detección y vigilancia del proceso fibrogénico.
MX367294B (es) * 2013-09-24 2019-08-05 Univ Mexico Nac Autonoma Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica.
EP3491388B1 (de) 2016-08-01 2021-09-01 Centre Hospitalier Universitaire d'Angers Multi-zielgerichteten fibrosetests
US20210022715A1 (en) * 2018-03-26 2021-01-28 The General Hospital Corporation Method for objective, noninvasive staging of diffuse liver disease from ultrasound shear-wave elastography
CN110070942A (zh) * 2019-04-22 2019-07-30 深圳市绘云生物科技有限公司 一种基于梯度提升树模型的慢性肝病风险评估系统
CN114550942B (zh) * 2022-02-16 2023-06-30 四川大学华西医院 一种肝脏显著纤维化预测模型及构建方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0823558B2 (ja) * 1984-11-27 1996-03-06 オ−ジエニクス リミテツド 検定装置
GB8803000D0 (en) * 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
JP3097866B2 (ja) * 1991-10-15 2000-10-10 マルティライト リミティド 標識試薬を使用した結合検定法
EP1015890B1 (de) * 1997-04-23 2005-11-30 INSTRUMENTATION LABORATORY S.p.A. Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
DE19731465A1 (de) * 1997-07-22 1999-01-28 Boehringer Mannheim Gmbh Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
EP1150123B1 (de) * 2000-04-28 2006-07-12 Bayer Aktiengesellschaft Diagnose von Leberfibrose mit Hilfe von Serummarkeralgorithmen
AU6738001A (en) * 2000-04-28 2001-11-20 Bayer Aktiengesellschaft Assessment of liver fibrosis scoring with serum marker algorithms
AU7812800A (en) * 2000-08-21 2002-03-04 Epigene Diagnosis method of fibrotic disease using biochemical markers
US6631330B1 (en) * 2000-08-21 2003-10-07 Assistance Publique-Hopitaux De Paris (Ap-Hp) Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
US6986995B2 (en) * 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis

Also Published As

Publication number Publication date
CA2575475A1 (en) 2006-02-16
WO2006015874A2 (en) 2006-02-16
US20070178443A1 (en) 2007-08-02
JP4516124B2 (ja) 2010-08-04
EP1626280A1 (de) 2006-02-15
CN101023356A (zh) 2007-08-22
WO2006015874B1 (en) 2006-11-23
WO2006015874A3 (en) 2006-09-28
WO2006015874A8 (en) 2006-04-06
ES2282780T3 (es) 2007-10-16
JP2008509411A (ja) 2008-03-27
DE602004004775T2 (de) 2007-11-22
ATE354097T1 (de) 2007-03-15
EP1626280B1 (de) 2007-02-14
CA2575475C (en) 2010-03-30

Similar Documents

Publication Publication Date Title
WO2006015874A3 (en) Method for diagnosing liver fibrosis
ATE419390T1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
CA2575405A1 (en) Method for diagnosing liver fibrosis
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE546734T1 (de) Risikomarker für eine herzkreislaufkrankheit
WO2006081521A3 (en) Methods for diagnosis and intervention of hepatic disorders
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
HK1208724A1 (en) Evaluating the efficacy of a treatment in a subject based on st2 levels st2
WO2003075745A3 (en) Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
Kumar et al. An investigation into the effect of a resin infiltrant on the micromechanical properties of hypomineralised enamel
WO2005029091A3 (en) Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE483982T1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
ES2685395T3 (es) Método para proporcionar pruebas diagnósticas no invasivas confiables
DE60016242D1 (de) Verfahren zur diagnose oder prognose von altersbedingter maculadegeneration
NZ599054A (en) Diagnosis of collagen IX destruction
ATE392622T1 (de) Verfahren zur diagnose von leberfibrose
WO2002022859A3 (en) Assessment of ecosystem health by evaluating multiple biomarkers in a nonhuman organism
DE602007008370D1 (de) Verfahren zur Detektion der in-vivo-Aktivität von Neurotrypsin, Verwendung des Verfahrens und Verwendung des C-terminal 22-kDa-Fragments als Biomarker bei der Diagnose und Überwachung von Störungen im Zusammenhang mit Neurotrypsin
ATE546547T1 (de) Diagnose der chronischen abstossung
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
ATE442456T1 (de) Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition